Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

IMS promotes Adel Al-Saleh to senior sales role

July 26, 2010 Sales and Marketing IMS, appointment, sales and marketing

IMS Health has promoted Adel Al-Saleh to the newly created position of senior vice president, sales and global account management. …
Appointment

GSK’s Arixtra set for expanded licence

July 26, 2010 Sales and Marketing Arixtra, Avandia, GlaxoSmithKline, rotarix

GlaxoSmithKline is set to receive a green light to use its anti-clotting drug Arixtra to prevent spontaneous superficial-vein thrombosis (SVT). …
News
Sandy_Royden

PM Society appoints new chair and vice-chair

July 26, 2010 Medical Communications, Sales and Marketing appointment, medical communications, pm society

Sandy Royden (pictured) has been elected as chairman of the PM Society and Dr Beverly Barr as vice-chairman. They join …
Appointment

Novartis’ Jonathan Peacock moves to Amgen

July 23, 2010 Sales and Marketing Amgen, appointment, sales and marketing

Amgen has appointed Jonathan Peacock executive VP and chief financial officer with effect from 1 September. He will move to …
Appointment

Roche sees slow sales amid market pressures

July 22, 2010 Sales and Marketing 2010 financials, Q2, Roche

Roche has posted average first half year results with pharma sales that showed only low single digit growth. They showed …
News

Abbott boosted by Solvay integration

July 22, 2010 Sales and Marketing 2010 financials, Abbott, Q2, Solvay

Abbott has posted a set of strong sales for the second quarter, buoyed by the integration of Solvay Pharmaceuticals and …
News

Legal costs dent GlaxoSmithKline’s Q2

July 22, 2010 Medical Communications, Sales and Marketing 2010 financials, GlaxoSmithKline, Q2

GSK has reported a loss for its second quarter due to litigation costs related to Avandia and other problems. In …
News

J&J post modest second quarter increase

July 21, 2010 Sales and Marketing 2010 financials, J&J, JJ, Q2

Johnson & Johnson has seen a modest increase in sales for the second quarter, buoyed primarily by international sales and …
News
Avastin packs

FDA advised to halt Avastin breast cancer use

July 21, 2010 Sales and Marketing Roche, avastin

In a hammer blow to Roche, an influential Food and Drug Administration vote has gone against its cancer drug Avastin. …
News

NICE’s methods to be put under the spotlight

July 19, 2010 Sales and Marketing MRC, NICE, cost-effectiveness

The Medical Research Council has awarded £2.3 million for new research into the academic methods underpinning advice given by NICE …
News

US approval for Sanofi’s Jevtana

July 19, 2010 Sales and Marketing Jevtana, Sanofi-Aventis, chemotherapy, prostate cancer

US regulators have approved Sanofi-Aventis’ chemotherapy agent Jevtana in combination with the steroid prednisone to treat men with prostate cancer. …
News

Elan expects Zonegran marketing probe to cost it $206m

July 19, 2010 Sales and Marketing Elan, Zonegran

Elan Corporation expects to pay $206.3 million to settle a US government investigation into the way it marketed its anti-epileptic …
News
Matthew_Speers

UCB’s Speers to lead European Medicines Group

July 19, 2010 Sales and Marketing European Medicines Group, UCB, appointment, sales and marketing

UCB Pharma’s managing director Matthew Speers has been elected chair of the European Medicines Group, taking over from Nigel Brooksby …
Appointment

NICE reaffirms positive opinion on Multaq

July 19, 2010 Sales and Marketing Multaq, NICE, antiarrhythmic, dronedarone

In its final draft guidance, UK cost-effectiveness body NICE has reaffirmed its previous positive opinion to recommend the limited use …
News

GSK takes £1.58bn hit from legal disputes

July 16, 2010 Sales and Marketing Avandia, GlaxoSmithKline, Paxcil, Seroxat

GlaxoSmithKline is set to pay £1.58 billion to settle three long-standing legal disputes, including litigation costs for its troubled diabetes …
News
The Gateway to Local Adoption Series

Latest content

Ofichem brings all brands under single trading name

April 23, 2026

Carvolix strengthens its Board of Directors, advisory board and governance structure

April 23, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

April 22, 2026

Incyclix Bio announces new additions to the Board

April 22, 2026

Remedy Plan Therapeutics Appoints Jotin Marango as CFO and CBO

April 21, 2026